## Abstract Quantitative studies using a ^51^Cr release assay were performed to analyse the time‐course of appearance and specificity of cytolytic cells in C57BI/6 mice inoculated with Moloney murine sarcoma virus (MSV). Various lymphoid organs were studied including spleen, mesenteric lymph nodes
Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV)-induced tumors
✍ Scribed by Tadayoshi Taniyama; Howard T. Holden
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- French
- Weight
- 874 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Macrophages isolated from regressing or progressing tumors induced by murine sarcoma virus (MSV) were tested for cytolytic activity in an 18‐h ^51^Cr release assay. Macrophages from the tumors of mice injected 14 days earlier with stocks of MSV‐producing regressor or progressor tumors had comparable levels of cytotoxicity. However, macrophages from the progressively growing tumors, 50–65 days after the inoculation with the progressor virus, had lower levels of cytotoxicity than those from the regressing tumors (day 14). On the other hand, macrophages from progressively growing MSV tumors (day 14) in nude mice had little or no detectable cytolytic activity. In a fractionation study, using the 1‐g velocity sedimentation technique, cells from regressing tumors (day 14) showed at least two peaks of cytolytic activity, one at about 4 mm/h and another at 6–7 mm/h, while cells from the progressing tumors (day 60) had only one peak of cytolytic activity, at about 4 mm/h. In contrast, none of the cell fractions of tumors from nude mice (day 14) showed cytolytic activity. Since bacterial lipopolysaccharide (LPS) has been shown to augment the cytolytic activity of primed macrophages, its effect on cells from MSV tumors was evaluated. Cytolytic activity of the cells from regressing or progressing tumors that had pre‐existing cytolytic activity was augmented by the addition of LPS during the assay period, but LPS treatment did not activate inactive fractions or change the distribution patterns of the cytolytic activity in fractions from 1‐g velocity sedimentation.
📜 SIMILAR VOLUMES
Twelve diflerent preparations of Murine Sarcoma Virus-Harvey ( M S V -H ) had leukaemogenic activity when tested in BALBIc and C,H/Bi mice or Sprague-Dawley rats, some of which ultimately developed generalized lymphocytic leukaemia instead of reacting rapidly and characteristically with sarcoma form
## Abstract Anti‐tumour cell‐mediated immune reactions were studied by the chromium release test (CRT) in mice bearing autochtonous Murine Sarcoma Virus (MSV)‐induced sarcomas or syngeneic transplants of lymphomas with various antigenic specificities. Cytotoxic lymphoid cells were detected during t
The genetics of late appearing MSV tumors showing a progressive growth pattern i n AKR mice was investigated. The late MSV tumor response in F, hybrids depended on the genetic background of the non-AKR parent. Within the 4-month observation period following virus injection, (CBA x AKR)F,, (DBA/ZxAKR
## Abstract Macrophages were isolated by adherence from an early‐passage chemically‐induced tumor in C57BL/6 mice and from its spontaneous lung metastases. Cytolytic activity was measured as release of [^3^H]‐thymidine from prelabelled tumor cells and cytostasis in a post‐labelling assay. Normal, u